Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Jackson J Liang , David J Callans Added: 3 years ago
As the population ages, the incidence of both AF and heart failure (HF) will continue to increase. By the year 2030, there will be an estimated >12 million patients with AF and >8 million patients with HF.1,2 A significant proportion of patients with HF have reduced (<50%) left ventricular ejection fraction (heart failure with reduced ejection fraction, HFrEF) and the coexistance of AF… View more

Heart Failure

Electrophysiology & Arrhythmia
Imaging in HFrEF
Author(s): Rebecca C Gosling , Abdallah Al-Mohammad Added: 1 year ago

Imaging & Diagnostics

Heart Failure
Medical Treatment of HFrEF in the Elderly
Author(s): Ivan Milinkovic , Marija Polovina , Andrew JS Coats , et al Added: 1 year ago

Standards & Guidelines

Heart Failure
Heart Failure Therapy in Older Patients
Author(s): Davide Stolfo , Gianfranco Sinagra , Gianluigi Savarese Added: 1 year ago

Heart Failure
Diabetes in Stage C Heart Failure
Author(s): Anjali Agarwalla , Jadry Gruen , Carli Peters , et al Added: 2 years ago

Heart Failure

Prevention & Chronic Conditions
Targeting Heart Rate To Improve Mortality In HF with John Cleland
Author(s): John GF Cleland Added: 6 years ago
John Cleland from Imperial College London, London, UK discusses 'Targeting heart rate to improve mortality in heart failure with reduced ejection fraction (HFrEF)'. This video highlights a comparison of sinus rhythm and atrial fibrillation at the Heart Failure 2017 (HFA) congress in Paris, France. Filmed by Radcliffe Cardiology on-site. View more

Heart Failure

Electrophysiology & Arrhythmia
Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
Author(s): Giuseppe Rosano , Ilaria Spoletini , Cristiana Vitale , et al Added: 3 years ago
Heart failure (HF) affects 1–2% of the population in developed countries and absorbs a significant amount of human and economic resources.1,2 HF is a complex syndrome characterised by a spectrum of symptoms and phenotypes: HF with preserved ejection fraction, HF with mid-range ejection fraction and HF with reduced ejection fraction (HFrEF).3 Differentiating patients according to left ventricular… View more

Heart Failure
Iron Deficiency and Heart Failure
Author(s): Pieter Martens Added: 2 years ago

Standards & Guidelines

Heart Failure
In-hospital Medical Therapy Initiation/Titration
Author(s): Zachary L Cox , Shuktika Nandkeolyar , Andrew J Johnson , et al Added: 1 year ago

Heart Failure
HFSA 22: PROVE-HF: Effect of Sacubitril/Valsartan in Patients with Mitral Regurgitation in Heart Failure with Preserved Ejection Fraction
Author(s): James L Januzzi Added: 1 year ago
HFSA 22 - Dr James Januzzi (Massachusetts General Hospital, US) outlines the findings of the PROVE-HF study, a trial which aimed to determine the effect of sacubitril/valsartan therapy on cardiac biomarkers in patients with mitral regurgitation in heart failure with reduced ejection fraction. Questions: 1. What was the ideology behind PROVE-HF? 2. What is the mechanism of action behind… View more

Heart Failure